Nashville, TN, United States of America

Douglas B Johnson

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Douglas B Johnson

Introduction

Douglas B Johnson is a notable inventor based in Nashville, TN, who has made significant contributions to the field of cancer treatment. With a total of three patents to his name, he has focused on developing methods and compositions that aim to improve cancer therapies.

Latest Patents

His latest patents include innovative approaches such as "Methods of treating cancer," which disclose techniques for treating melanomas. Another significant patent is "Immune checkpoint molecular fitness profiling by mass spectrometry," which relates to the analysis of immune checkpoint proteins involved in cancer. This patent provides methods for determining abundance ratios of various immune checkpoint proteins, such as PD-1, PD-L1, and PD-L2, present in biospecimen samples through mass spectrometry analysis. These methods offer alternative platforms for diagnosing and treating cancer, particularly in cases where traditional antibody recognition is ineffective.

Career Highlights

Throughout his career, Douglas has worked with esteemed organizations, including Vanderbilt University and Foundation Medicine, Inc. His work has been instrumental in advancing cancer research and treatment methodologies.

Collaborations

He has collaborated with notable professionals in the field, including Daniel C Liebler and Lisa J Zimmerman, further enhancing the impact of his research and innovations.

Conclusion

Douglas B Johnson's contributions to cancer treatment through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches continue to pave the way for new therapeutic strategies in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…